Other oral treatments for genital herpes have a limited effect. Studies show that they reduce symptoms by only one day. - CBCD
Rochester, NY (PRWEB) August 29, 2013
The mission of the CBCD is to advance research on the biology of foreign DNA. Thus, the CBCD is excited that a new clinical study has provided evidence for the safety and effectiveness of a natural product. That product is Gene-Eden-VIR, and it was designed to reduce foreign DNA that comes from the herpes virus (1). Also, the Center believes that the product is the only treatment capable of decreasing the concentration of latent herpes virus in infected individuals. The study was published in the peer reviewed, scientific journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs.
This paper is unique because it reports a clinical study on a proprietary, patent protected, natural formula in a peer reviewed, medical journal.
Other oral treatments for genital herpes have a limited effect. Studies show that they reduce symptoms by only one day. For instance, according to a study published in April of 2004 in the Annals of Pharmacotherapy, “Treatment with oral antivirals decreases the duration of (genital herpes) lesion episodes and pain by approximately one day; however, the antivirals do not abort lesions from developing (2).” In fact, “The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day (2).” These treatments include penciclovir, acyclovir, famciclovir, and valaciclovir.
Moreover these treatments are associated with serious side effects. For example, The American Journal of Therapeutics on March 22, 2013 noted that, “Serious neuropsychiatric side effects have been demonstrated with the use of valacyclovir (Valtrex)….” (3) In addition, Drugs.com says on its website that, tremor, visual and auditory hallucinations, confusion and coma are neuropsychiatric side effects, and all have been associated with the use of Valacyclovir (4).
In contrast, Gene-Eden-VIR was shown to safely reduce genital herpes symptoms with no side effects. In fact, study participants “reported no side effects after taking Gene-Eden-VIR (1).”
Study authors wrote that, “individuals infected with HSV, …reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (1).” The study authors also wrote that “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (1).”
Since the CBCD believes in Dr. Polansky’s theory that identifies latent viruses as the cause of most major diseases, the Center sees Gene-Eden-VIR as an important first step towards curing a latent herpes infection.
To view the entire paper,
We invite the media to contact us for interviews at: info(at)buy-gene-eden(dot)com or phone 585-250-9999.
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.